Atrix Clarifying Toner

Description

Atrix™ Clarifying Toner is a product manufactured by PureTek Corporation, located in Panorama City, California, USA. The formulation is designed for use in skin care applications, providing clarifying properties.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries and clears acne pimples, acne blemishes, whiteheads, and blackheads. Additionally, it helps prevent the development of new acne pimples, acne blemishes, whiteheads, and blackheads.

There are no teratogenic effects associated with this drug. Furthermore, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the product. The recommended method of application involves moistening a cotton ball and applying a thin layer to the entire affected area. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive skin drying. Based on the patient's response, the frequency of application may be gradually increased to two or three times daily, as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day. The use of this product should always be under the supervision of a medical practitioner to ensure safety and efficacy.

Contraindications

Use is contraindicated in patients who experience skin irritation or worsening of skin conditions.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Skin irritation and dryness may be exacerbated if this product is used concurrently with other topical acne medications. It is advisable to limit the use of topical acne treatments to one at a time to minimize the risk of irritation. In the event that the product comes into contact with the eyes, it is imperative to rinse immediately with water to mitigate potential harm.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any skin irritation occurs or worsens during treatment.

In cases of accidental ingestion, it is crucial to obtain emergency medical assistance or contact a Poison Control Center without delay to ensure appropriate management of the situation.

Side Effects

Patients using this product should be aware that it is for external use only and is flammable; therefore, it should be kept away from fire or flame.

Common adverse reactions include skin irritation and dryness, which are more likely to occur if another topical acne medication is used concurrently. In such cases, it is advised that patients use only one topical acne medication at a time. Should skin irritation occur or worsen, patients are instructed to stop use and consult a healthcare professional.

In the event of accidental ingestion, it is crucial to keep the product out of reach of children. If swallowed, patients should seek medical assistance or contact a Poison Control Center immediately. Additionally, if the product comes into contact with the eyes, it should be rinsed out promptly with water.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Atrix Clarifying Toner (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication only under the direction of a medical practitioner. It is essential to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of Atrix Clarifying Toner in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the absence of data necessitates careful monitoring and assessment of individual patient needs.

Pregnancy

There are no specific pregnancy-related warnings, precautions, or dosage modifications associated with the use of Atrix Clarifying Toner (salicylic acid liquid). While the safety of salicylic acid during pregnancy has not been established through controlled studies, healthcare professionals should consider the potential risks and benefits when recommending this product to pregnant patients. As with any topical treatment, it is advisable for women of childbearing potential to consult with their healthcare provider prior to use to ensure appropriate management of their skincare needs during pregnancy.

Lactation

No information related to nursing mothers or lactation is provided in the drug insert for Atrix Clarifying Toner. Therefore, the effects on breastfed infants and the excretion of the product in breast milk are not known. Healthcare professionals should consider this lack of data when advising lactating mothers regarding the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert for ATRIX CLARIFYING TONER (salicylic acid liquid).

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for healthcare providers to instruct patients to discontinue use and consult a doctor if they experience any skin irritation or if the irritation worsens.

Healthcare providers should inform patients that the likelihood of skin irritation and dryness may increase if they are using another topical acne medication concurrently. In such cases, patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, patients should be instructed to rinse their eyes immediately with water if the product comes into contact with them. This precaution is essential to prevent potential eye irritation or damage.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled room temperature, specifically between 20° to 25°C (68° to 77°F), in accordance with USP guidelines.

To ensure the integrity of the product, it must be protected from freezing and should be kept away from excessive heat. Proper handling and storage conditions are crucial for maintaining the product's efficacy and safety.

Additional Clinical Information

Patients should ensure that the skin is thoroughly cleaned before applying the product. A moistened cotton ball should be used to cover the entire affected area with a thin layer, applied one to three times daily. It is recommended to start with one application daily and gradually increase to two or three times daily as needed or as directed by a clinician. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

Clinicians should advise patients to use the product under their direction to ensure safe and effective use.

Drug Information (PDF)

This file contains official product information for Atrix Clarifying Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)